44 Biggest Movers From Yesterday


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Gainers

  • American Electric Technologies, Inc (NASDAQ:AETI) shares surged 126.35 percent to close at $1.675 on Monday after the company’s M&I Electric business announced a $14 million project with a leading Engineering, Procurement and Construction firm.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) shares gained 47.86 percent to close at $38.31 after the company reported updated interim Phase 1 clinical study results with DCC-2618 at the ASCO Annual Meeting.
  • Anavex Life Sciences Corp. (NASDAQ:AVXL) gained 31.71 percent to close at $3.78.
  • LiveXLive Media, Inc. (OTC:LIVX) rose 24.94 percent to close at $5.56.
  • Genomic Health, Inc. (NASDAQ:GHDX) shares rose 23.07 percent to close at $48.84 after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
  • Highpower International Inc (NASDAQ:HPJ) shares rose 18.26 percent to close at $3.40 on Monday.
  • Renmin Tianli Group, Inc. (NASDAQ:ABAC) gained 17.51 percent to close at $2.55.
  • BIO-key International, Inc. (NASDAQ:BKYI) rose 17.04 percent to close at $2.61. BIO-key International disclosed that it has completed conversion of all outstanding preferred stock into common stock at a conversion price of $3.60 per share.
  • Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose 15.87 percent to close at $23.00.
  • Companhia Siderúrgica Nacional (NYSE:SID) climbed 14.98 percent to close at $2.38 on Monday.
  • ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) shares rose 14.92 percent to close at $9.78.
  • ProQR Therapeutics N.V. (NASDAQ:PRQR) climbed 13.91 percent to close at $6.55.
  • Sogou Inc. (NYSE:SOGO) gained 13.22 percent to close at $10.88 on Monday.
  • Evolus, Inc. (NASDAQ:EOLS) gained 11.77 percent to close at $30.49.
  • Arcturus Therapeutics Ltd. (NASDAQ:ARCT) shares rose 11.55 percent to close at $6.28 on Monday.
  • CSS Industries, Inc. (NYSE:CSS) rose 11.19 percent to close at $17.99. DA Davidson upgraded CSS Industries from Neutral to Buy.
  • Denali Therapeutics Inc. (NASDAQ:DNLI) gained 10.4 percent to close at $20.80.
  • Immunomedics, Inc. (NASDAQ:IMMU) shares rose 10.26 percent to close at $25.04. Clovis Oncology and Immunomedics reported a planned clinical collaboration to study combination therapies in metastatic triple-negative breast and urothelial cancers.
  • Petróleo Brasileiro S.A. - Petrobras (NYSE:PBRA) shares rose 9.7 percent to close at $9.39.

 

Losers

  • Nektar Therapeutics (NASDAQ:NKTR) shares tumbled 41.82 percent to close at $52.57 on Monday. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
  • Jounce Therapeutics, Inc. (NASDAQ:JNCE) dropped 33.48 percent to close at $7.47 after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
  • Kandi Technologies Group, Inc. (NASDAQ:KNDI) shares fell 29.36 percent to close at $3.85. The company announced that it was acquiring Sportsman Country for $10 million in restricted shares.
  • Mersana Therapeutics, Inc. (NASDAQ:MRSN) slipped 23 percent to close at $15.94 after the company presented interim dose-escalation data on XMT-1522 in select cancers at the ASCO 2018.
  • Daqo New Energy Corp. (NYSE:DQ) shares declined 20.71 percent to close at $41.80 on Monday after dropping 8.57 percent on Friday.
  • Vaxart, Inc. (NASDAQ:VXRT) fell 18.32 percent to close at $4.28 as the company disclosed that its Phase 2 trial of teslexivir did not meet its primary endpoint.
  • AC Immune SA (NASDAQ:ACIU) dropped 18.27 percent to close at $8.320.
  • CytomX Therapeutics, Inc. (NASDAQ:CTMX) declined 16.26 percent to close at $21.38.
  • Amtech Systems, Inc. (NASDAQ:ASYS) fell 16.13 percent to close at $8.32 on Monday.
  • Aduro BioTech, Inc. (NASDAQ:ADRO) shares dropped 15.38 percent to close at $7.15.
  • RF Industries, Ltd. (NASDAQ:RFIL) shares slipped 14.79 percent to close at $6.05 on Monday.
  • Gevo, Inc. (NASDAQ:GEVO) shares fell 14.58 percent to close at $4.10 on Monday.
  • Canadian Solar Inc. (NASDAQ:CSIQ) shares dropped 13.86 percent to close at $13.515.
  • Obalon Therapeutics, Inc. (NASDAQ:OBLN) shares dipped 13.04 percent to close at $2.20.
  • Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shares tumbled 12.29 percent to close at $11.56.
  • Zymeworks Inc. (NYSE:ZYME) fell 12.21 percent to close at $19.19 on Monday.
  • Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) dropped 12.02 percent to close at $7.76
  • G1 Therapeutics, Inc. (NASDAQ:GTHX) shares fell 10.16 percent to close at $39.17 after the company presented Phase 1b data on G1T38 in combination with faslodex for treatment of breast cancer at the ASCO 2018.
  • PPDAI Group Inc. (NYSE:PPDF) shares declined 9.75 percent to close at $6.94 on Monday.
  • Blueprint Medicines Corporation (NASDAQ:BPMC) shares dropped 9.24 percent to close at $76.67. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
  • JinkoSolar Holding Co., Ltd. (NYSE:JKS) fell 9.05 percent to close at $13.77 on Monday after dropping 14.07 percent on Friday.
  • NovoCure Limited (NASDAQ:NVCR) dropped 7.51 percent to close at $29.55. Novocure will present INNOVATE-3 Phase 3 pivotal trial design in recurrent ovarian cancer at the ASCO Annual Meeting 2018.
  • Co-Diagnostics, Inc. (NASDAQ:CODX) fell 7.31 percent to close at $4.44 on Monday after climbing 65.17 percent on Friday.
  • Tactile Systems Technology, Inc. (NASDAQ:TCMD) slipped 7.08 percent to close at $46.87. BTIG Research downgraded Tactile Systems Technology from Buy to Neutral.
  • Viper Energy Partners LP (NASDAQ:VNOM) dropped 6.18 percent to close at $28.52. Stifel Nicolaus downgraded Viper Energy Partners from Buy to Hold.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasLosersMovers From YesterdayTop GainersYesrerday's Gainers